Polar Bear Genome BioPharma announce opening of new building
LEDUC, AB, Aug. 6, 2019 /CNW/ - Polar Bear Genome (PBG) BioPharma Canada Corporation, a Canadian company committed to becoming a world leader in the development and manufacturing of evidence-based natural health products and medicinal cannabis products using its proprietary GenBioChem™ fingerprinting technology platform, announced today their ribbon cutting event to be held on August 8th, 2019 to officially open its 25,000 SQF research and manufacturing facility. The building's offices will open for work as construction takes place to complete the level 11 ISO, GMP and EU GMP facility in Leduc, Alberta. The completed facility will contain both a manufacturing and research/analytical lab to perform proprietary extractions, isolations, formulations and testing of Canada-based medicinal herbs, as well as medicinal cannabis.
|
Dr. Jacqueline Shan, President, CEO and Chief Science Officer, Polar Bear Genome BioPharma’s |
